References
- Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol. 2010;48:2940–2947. doi:10.1128/JCM.00636-10
- Gadsby NJ, Russell CD, McHugh MP, et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62:817–823. doi:10.1093/cid/civ1214
- Trombetta H, Faggion HZ, Leotte J, Nogueira MB, Vidal LR, Raboni SM. Human coronavirus and severe acute respiratory infection in Southern Brazil. Pathog Glob Health. 2016;110:113–118. doi:10.1080/20477724.2016.1181294
- Corman VM, Lienau J, Witzenrath M. Coronaviruses as the cause of respiratory infections. Internist. 2019;60:1136–1145. doi:10.1007/s00108-019-00671-5
- Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa2001316
- Gorbalenya AE, Baker SC, Baric RS; Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–544. doi:10.1038/s41564-020-0695-z
- Du X, Wu G, Zhu Y, Zhang S. Exploring the epidemiological changes of common respiratory viruses since the COVID-19 pandemic: a hospital study in Hangzhou, China. Arch Virol. 2021;166(11):3085–3092. doi:10.1007/s00705-021-05214-8
- Liu P, Xu M, Cao L, et al. Impact of COVID-19 pandemic on the prevalence of respiratory viruses in children with lower respiratory tract infections in China. Virol J. 2021;18(1):159. doi:10.1186/s12985-021-01627-8
- Zhao MC, Li GX, Zhang D, et al. Clinical evaluation of a new single-tube multiplex reverse transcription PCR assay for simultaneous detection of 11 respiratory viruses, Mycoplasma pneumoniae and Chlamydia in hospitalized children with acute respiratory infections. Diagn Microbiol Infect Dis. 2017;88(2):115–119. doi:10.1016/j.diagmicrobio.2017.03.010
- Agca H, Akalin H, Saglik I, Hacimustafaoglu M, Celebi S, Ener B. Changing epidemiology of influenza and other respiratory viruses in the first year of COVID-19 pandemic. J Infect Public Health. 2021;14(9):1186–1190. doi:10.1016/j.jiph.2021.08.004
- Zhang RX, Chen DM, Qian Y, et al. Surges of hospital-based rhinovirus infection during the 2020 coronavirus disease-19 (COVID-19) pandemic in Beijing, China. World J Pediatr. 2021;17(6):590–596. doi:10.1007/s12519-021-00477-2
- Edridge AWD, Kaczorowska J, Hoste ACR, et al. Seasonal coronavirus protective immunity is short-lasting. Nat Med. 2020;26(11):1691–1693. doi:10.1038/s41591-020-1083-1
- van der Hoek L. Human coronaviruses: what do they cause? Antivir Ther. 2007;12(4 Pt B):651–658. doi:10.1177/135965350701200S01.1
- Dijkman R, Jebbink MF, Gaunt E, et al. The dominance of human coronavirus OC43 and NL63 infections in infants. J Clin Virol. 2012;53:135–139. doi:10.1016/j.jcv.2011.11.011
- Lawrenz J, Xie Q, Zech F, et al. Severe acute respiratory syndrome coronavirus 2 vaccination boosts neutralizing activity against seasonal human coronaviruses. Clin Infect Dis. 2022;75(1):e653–661. doi:10.1093/cid/ciac057
- Kaplonek P, Wang C, Bartsch Y, et al. Early cross-coronavirus reactive signatures of humoral immunity against COVID-19. Sci Immunol. 2021;6:eabj2901. doi:10.1126/sciimmunol.abj2901
- Dangi T, Palacio N, Sanchez S, et al. Cross-protective immunity following coronavirus vaccination and coronavirus infection. J Clin Invest. 2021;131(24):e151969. doi:10.1172/JCI151969